| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT03048136 Details | 2018-04-17 Interventional | 3 | 0 | Ipilimumab Nivolumab Carcinoma, Non-… Lung Neoplasms Non-Small Cell … | Business objective has changed - | |||
| NCT00854581 Details | 2018-04-17 Interventional | 4 | 13 | Interferon alph… Interferon-alph… Interferons Peginterferon a… Valproic Acid Zidovudine Leukemia Leukemia, T-Cel… Leukemia-Lympho… Lymphoma Precancerous Co… Precancerous/No… | Investigator Decision - | |||
| NCT03497715 Details | 2018-04-13 Interventional | 1 | 6 | Ibuprofen Healthy Subject… | On completion of part 1 it was felt that there would be no benefit in completing part 2 - | |||
| NCT02933684 Details | 2018-04-13 Interventional | 2 | 0 | Cycloserine Anxiety Disorde… Phobia, Social Social Anxiety … | Unable to access components necessary to be able to run the study. - | |||
| NCT02428062 Details | 2018-04-13 Interventional | 2/3 | - | Dopamine Ephedrine Epinephrine Norepinephrine Oxymetazoline Phenylephrine Vasoconstrictor… Cognitive Dysfu… Postoperative C… Post-operative … | Pending Pilot study results evaluation - | |||
| NCT00763009 Details | 2018-04-13 Interventional | 4 | 8 | Dipyridamole Coronary Artery… | Limited numbers of patients qualified for trial Trial terminated early due to poor patient enrollment. All patients responded hemodynamically. Therefore, analysis of responders vs non-responders could not be performed. Adenosine transporter was not analyzed since there was no comparator group. | |||
| NCT00227136 Details | 2018-04-13 Interventional | 3 | - | Serotonin Carcinoid Tumor Neuroendocrine … Carcinoid Tumor… | - - | |||
| NCT00089544 Details | 2018-04-13 Interventional | 2 | 23 | Dacarbazine Doxorubicin Ifosfamide Imidazole Isophosphamide … Lenograstim Liposomal doxor… Thalidomide Sarcoma Recurrent Adult… Stage I Adult S… Stage II Adult … Stage III Adult… | - This study closed early due to unacceptably high rate of thromboembolic events in Cohort A and due to low accrual in Cohort B. For this reason efficacy endpoints other than response to pre-operative therapy were not reported. | |||
| NCT03131700 Details | 2018-04-12 Interventional | 1 | 0 | Bevacizumab Healthy | Decision of the Sponsor - | |||
| NCT00096187 Details | 2018-04-12 Interventional | 2 | - | Pemetrexed Gestational Tro… Trophoblastic N… Gestational Tro… | - - | |||
| NCT00005029 Details | 2018-04-12 Interventional | 2 | [1 Refs] | - | Topotecan Ovarian Cancer Primary Periton… | - - | ||
| NCT00003054 Details | 2018-04-12 Interventional | 2 | [1 Refs] | - | Paclitaxel Sarcoma | - - | ||
| NCT02810483 Details | 2018-04-11 Interventional | 3 | 69 | Topiramate Prader-Willi Sy… Syndrome | - - | |||
| NCT02209155 Details | 2018-04-11 Interventional | 2 | 1 | Verapamil Cluster Headach… Headache Episodic Cluste… | - - | |||
| NCT03385395 Details | 2018-04-10 Interventional | 2 | 0 | Alpha 1-Antitry… Alpha 1-Antitry… | IND has been closed. - | |||
| NCT02155634 Details | 2018-04-10 Interventional | 3 | 0 | Lenalidomide Blood Protein D… Hematologic Dis… Multiple Myelom… Neoplasms, Plas… Paraproteinemia… Neoplasms Plasma Cells Therapeutic Use… | The study was terminated due to poor feasibility and lack of interest at the participating
sites. - | |||
| NCT03241017 Details | 2018-04-09 Interventional | 2 | 0 | Durvalumab Lymphoma Lymphoma, Large… | Celgene withdrew the support for this study (Durvalumab cannot be provided) - | |||
| NCT02911480 Details | 2018-04-06 Interventional | 1 | 0 | Oxytocin Healthy Women o… | Study/financial issues - | |||
| NCT02267408 Details | 2018-04-06 Interventional | 1/2 | 42 | Warfarin Hypoprothrombin… Hypoprothrombin… | Terminated by sponsor - | |||
| NCT03061136 Details | 2018-04-05 Interventional | 4 | 0 | Clonazepam Psychotic Disor… Schizophrenia Schizoaffective… Schizophrenifor… | Delays in equipment procurement prevented the start of the study in time - |